10 Best IPO Stocks To Buy Heading into 2025
The current climate in the IPO market suggests a potential rebound, particularly looking ahead to 2025.
Apogee Therapeutics Inc. (APGE)
Market is closed
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $49.85 | 12,500 | Director | 20,000 | 2024-12-12 | Filing | |
| $49.02 | 7,500 | Director | 7,500 | 2024-12-12 | Filing | |
| $17.00 | 1,750,000 | Director | 1,750,000 | 2023-07-13 | Filing | |
| $17.00 | 892,529 | Director | 892,529 | 2023-07-13 | Filing | |
| $17.00 | 1,992,734 | Director | 1,992,734 | 2023-07-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $50.00 | 455 | Officer | 258,073 | 2024-12-11 | Filing | |
| $48.62 | 4,085 | Officer | 258,528 | 2024-12-11 | Filing | |
| $46.07 | 6,665 | Officer | 260,798 | 2024-12-04 | Filing | |
| $47.19 | 1,672 | Officer, Director | 1,324,487 | 2024-12-04 | Filing | |
| $46.50 | 13,328 | Officer, Director | 1,326,159 | 2024-12-04 | Filing |
News See All
10 Best Hot Stocks To Buy Right Now
While the market is seeing significant positives after the Fed rate cut, there have been some pressures.
Billionaire Hedge Funds
